Podcasts about resistant

Episode Description: You have been cutting carbs to lose weight and your blood sugar still will not move. What if you have been avoiding the one carbohydrate that was actually working in your favor the whole time? Resistant starch is a carbohydrate your body cannot digest. Instead of spiking your blood sugar, it travels to your gut bacteria intact, feeds them, and triggers a chain reaction that improves insulin sensitivity, blunts post-meal glucose spikes, and in human controlled trials is linked to measurable reductions in visceral fat. And here is the part that might surprise you: the same food can have a completely different metabolic effect depending on how you prepare it. Cooking and then cooling a potato or a plate of rice meaningfully increases its resistant starch content. Same food. Different biology. In this episode, you will learn:  • How resistant starch feeds your gut bacteria to produce butyrate, one of the most powerful anti-inflammatory compounds in the body, and how that chain reaction directly improves how your body handles blood sugar and insulin  • What the randomized controlled trial data actually shows for weight loss, visceral fat reduction, and insulin sensitivity, including the dose ranges used in the studies and how long it takes to see results  • The exact foods to start with, why you have to go slow, and what happens to your gut if you jump straight to 40 grams a day This is a free tool. No supplement required. Product reviews assess both brand transparency and product quality. If a company doesn't respond to our outreach, it doesn't automatically mean their product is low quality but it does mean they're failing their customers on transparency and communication. We reach out multiple times. No response isn't an oversight, it's a choice. And consumers deserve better. Timestamps: 0:00 - Intro 1:30 - What Makes Resistant Starch Different From Every Other Carbohydrate 3:30 - The Cooking Trick That Changes How Your Body Responds to Ordinary Food 5:00 - How Your Gut Bacteria Turn This Into One of the Most Powerful Anti-Inflammatory Compounds in the Body 7:00 - The GLP-1 Connection and What the Research Actually Says (vs. What Marketing Says) 9:00 - What Dr. G Has Seen in 12 Years of Clinical Practice With Patients 11:00 - What the Randomized Trials Actually Show on Blood Sugar, Insulin and Visceral Fat1 3:30 - How to Actually Use It: Doses, Best Food Sources and the One Mistake Everyone Makes 16:00 - The Honest Limitations (And Why It's Still Worth Trying) Learn more about your ad choices. Visit megaphone.fm/adchoices

After decades of caring for patients in underserved communities around the world, Dr. Glenn Geelhoed suddenly became the patient. A diagnosis of drug-resistant tuberculosis forced him to stop running, miss his 50th Marine Corps Marathon, and endure months of difficult treatment. But he never stopped seeing himself as a runner. “It's not the finish line. It's the run. It's called living.” #DrugResistantTB #Tuberculosis #RunningMotivation #MarathonRunner #GlobalHealth #MissionToHeal #Resilience #PhysicianStories #Healthcare #LebanesePhysiciansPodcast #youtubeshorts On YouTube @thelebanesephysicianspodcast and on all podcast apps

Kelvin Cooper, CEO of Lakewood-Amedex Biotherapeutics, has developed a novel class of antimicrobials that operate by disrupting bacterial and fungal cell membranes, rapidly killing the microorganisms. Traditional antimicrobials work by inhibiting bacterial growth, but bacteria have evolved resistance mechanisms against all drug classes, with multidrug-resistant strains becoming increasingly common. The company is focused on treating infected diabetic foot ulcers with a topical gel formulation that locally delivers a high drug concentration while minimizing systemic side effects. Kelvin explains, "You can go back all the way to the discovery of penicillin a century ago, and there was tremendous excitement around that. And then through the 40s, when they figured out how to deep tank ferment the antibacterials, the beta lactams, as it was then, again, there was no real indication that resistance was going to be that big of a problem."   "What we have done at Lakewood-Amedex Biotherapeutics is we've discovered a completely new class of antimicrobials, and it's probably good to give some context of how most antimicrobials work. Typically, what they do is they will stop the bacteria from dividing and growing, and that prevents the bacteria from causing an infection. Now the bacteria and fungi have figured out ways to mutate around that. So they have a different way of building cell walls, for example. And that has become the big problem. Our class of agents hits a completely different type of mechanism. We believe that what happens, and we have good scientific data to show this, is that this class of agents attacks the membrane of bacteria and fungi. It disrupts the membrane, which allows the contents of whatever microbe it is to spill out, and it immediately kills the bacteria extremely rapidly." #LakewoodAmedex #AntimicrobialResistance #AMR #InfectiousDiseases #Antibiotics #Antimicrobials #DiabeticFoot #DiabeticFootUlcer #HealthcareInnovation   #DiabeticCare #Biotech #PublicHealth #MedicalBreakthrough $LABT lakewoodamedex.com Download the transcript here  

Kelvin Cooper, CEO of Lakewood-Amedex Biotherapeutics, has developed a novel class of antimicrobials that operate by disrupting bacterial and fungal cell membranes, rapidly killing the microorganisms. Traditional antimicrobials work by inhibiting bacterial growth, but bacteria have evolved resistance mechanisms against all drug classes, with multidrug-resistant strains becoming increasingly common. The company is focused on treating infected diabetic foot ulcers with a topical gel formulation that locally delivers a high drug concentration while minimizing systemic side effects. Kelvin explains, "You can go back all the way to the discovery of penicillin a century ago, and there was tremendous excitement around that. And then through the 40s, when they figured out how to deep tank ferment the antibacterials, the beta lactams, as it was then, again, there was no real indication that resistance was going to be that big of a problem."   "What we have done at Lakewood-Amedex Biotherapeutics is we've discovered a completely new class of antimicrobials, and it's probably good to give some context of how most antimicrobials work. Typically, what they do is they will stop the bacteria from dividing and growing, and that prevents the bacteria from causing an infection. Now the bacteria and fungi have figured out ways to mutate around that. So they have a different way of building cell walls, for example. And that has become the big problem. Our class of agents hits a completely different type of mechanism. We believe that what happens, and we have good scientific data to show this, is that this class of agents attacks the membrane of bacteria and fungi. It disrupts the membrane, which allows the contents of whatever microbe it is to spill out, and it immediately kills the bacteria extremely rapidly." #LakewoodAmedex #AntimicrobialResistance #AMR #InfectiousDiseases #Antibiotics #Antimicrobials #DiabeticFoot #DiabeticFootUlcer #HealthcareInnovation   #DiabeticCare #Biotech #PublicHealth #MedicalBreakthrough $LABT lakewoodamedex.com Listen to the podcast here  

Send us Fan MailWe stack up the week's wine news with a mix of hard numbers and genuine bright spots, from rock-bottom bulk prices to a more diverse global awards landscape. We also get real about mental health in the Australian wine industry and why connection, provenance and ethics still matter when times are tough. • Australian bulk Shiraz and Cabernet sitting at extreme low values • what bulk wine is for and why shipping in bulk can be cheaper and more sustainable • how oversupply and the post-China hangover keep pressure on growers • Decanter World Wine Awards results as a snapshot of quality and global change • emerging regions gaining recognition including England, China, Serbia and Uruguay • a Sydney high school site hosting CSIRO disease-resistant grapevine trials • powdery mildew and downy mildew pressure in warm, wet climates • crossbreeding versus GMO and how the wine industry thinks about it • mental health pressures from isolation, long hours, uncertainty and access to alcohol • practical support ideas like community breakfasts, viticulture groups and Rootlings • a Halliday column on provenance, ethics and finding hope in wine Yeah, go read it. It's called It Might Take A Graveyard to Show It, but there's Life in Wine Yet.  Follow us on instagram @winewithmegandmeland TikTok! @winewithmegmel

How Targeted Therapies Are Reshaping Treatment for Platinum-Resistant Ovarian Cancer Platinum-resistant ovarian cancer remains one of the most challenging settings in oncology, with limited treatment options and historically poor outcomes for many patients. On this episode of Unscripted, the AMCP Podcast, guest host Abby Kim, PharmD, BCOP, Senior Director of Clinical Strategy and Oncology Specialty Solutions at Prime Therapeutics, sits down with Kathleen Moore, MD, Deputy Director of the Fred & Pamela Buffett Cancer Center and Professor of Obstetrics and Gynecology at Nebraska Medicine, to discuss the evolving treatment landscape for recurrent ovarian cancer and the growing role of biomarker-driven care. Dr. Moore explores the history and challenges of treating platinum-resistant disease, reviews the clinical evidence behind ELAHERE®, examines the importance of folate receptor alpha testing, and shares insights on treatment sequencing, patient-reported outcomes, safety and tolerability considerations, and emerging therapies that may further expand options for patients and inform decision-making across managed care. Sponsored by Abbvie, Inc. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Jak vypadá „boj zlé AI proti hodné AI“? O tom něco ví Martin Rehák, zakladatel firmy Resistant AI, která pomocí umělé inteligence chytá zločince v kyberprostoru a chrání peníze bank a pojišťoven ve válce algoritmů. „Statisticky benefitují zločinci z nástupu AI mnohem více než finanční instituce nebo firmy. Poslední dva roky radikálně stoupá úspěšnost a sofistikovanost podvodníků. Zvládli přechod k byznysu poháněnému umělou inteligencí podstatně lépe, než většina českých podniků,“ popisuje drsnou realitu Rehák v podcastu Faktor AI.

In today's episode, we spoke with David O'Malley, MD. Dr O'Malley is a professor in the Department of Obstetrics and Gynecology at The Ohio State University College of Medicine and the director of the Division of Gynecologic Oncology at The Ohio State University Comprehensive Cancer Center–James in Columbus, Ohio. In our exclusive interview, Dr O'Malley discussed his approach to treatment selection and sequencing in platinum-resistant ovarian cancer, a disease setting he described as representing the highest unmet need in the field. He emphasized the central role of clinical trial enrollment and biomarker-driven decision-making, alongside practical patient-centered considerations, such as infusion schedule and quality of life.He highlighted the growing importance of antibody-drug conjugates (ADCs) in this setting, noting that folate receptor alpha and HER2 are the two biomarkers most relevant to current practice. Dr O'Malley outlined how National Comprehensive Cancer Network guidelines support treatment across a broader range of expression levels than initial approvals reflected, citing emerging data suggesting activity even at lower expression thresholds. He also addressed payload sequencing, explaining that outside of a clinical trial, he currently uses topoisomerase I–based ADCs and antimicrotubule-based ADCs each one time only, and remains open to targeting the same antigen again if the payload differs.The discussion also touched on combination strategies, resistance biology, and the evolving role of immunotherapy following the survival benefit observed with pembrolizumab (Keytruda) in the phase 3 KEYNOTE-B96 trial (NCT05116189). Dr O'Malley expressed enthusiasm for next-generation payloads, dual-target approaches, and the potential for bispecific antibodies and novel DNA damage response–targeting agents to define the post-ADC treatment landscape.Finally, Dr O'Malley underscored the need for more tumor biopsies to better characterize resistance mechanisms and called for expanded pharmaceutical investment in retreatment and cross-resistance studies to guide future sequencing decisions.

Listen in to learn from Cristina Saura Manich, MD, PhD and Giampaolo Bianchini, MD about practical approaches to PI3K pathway testing, PI3K/AKT-targeted treatment options, and endocrine-based sequencing in metastatic breast cancer. Presenters: Cristina Saura Manich, MD, PhD Head, Breast Cancer Unit Medical Oncology Service Vall d'Hebron University Hospital Breast Cancer Program, Vall d'Hebron Institute of Oncology (VHIO) Barcelona, Spain Giampaolo Bianchini, MD Associate Professor, Universita Vita-Salute San Raffaele Head, Breast Cancer Group, Department of Medical Oncology Head, Clinical Translational and Immunotherapy Research IRCCS Ospedale San Raffaele Milan, Italy Get access to all of our new podcasts by subscribing to the Decera Clinical Education Oncology Podcast on Apple Podcasts, YouTube Music, or Spotify. Visit the program page for more content associated with this discussion.https://bit.ly/4p6W8gP Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

 EPISODE DESCRIPTION I sat down with Pasha from Igra Labs in Berlin to dig into one of the most contrarian bets in Web3 right now , EVM on proof of work. Pasha walks me through why he left the Ethereum ecosystem, what drew him to Kaspa's BlockDAG architecture, and why he believes proof of work offers something proof of stake simply cannot: real fairness. We get into MEV resilience, censorship resistance, and why 10 blocks per second with no centralized sequencer changes everything for DeFi builders. We also cover Multitude, their brand new sovereign execution zones product, and why AI agents might finally be the user experience layer that makes Web3 click for everyone. If you're a founder, a builder, or just someone curious about where the next wave of adoption is coming from, this one is packed.  CONNECT Igra Labs Website: https://igralabs.com/heroDeploy your sovereign finance chain infrastructure https://igralabs.com/multitude Igra Labs Twitter/X: https://x.com/Igra_LabsPavel LinkedIn: https://www.linkedin.com/in/emdin/Web3 with Sam Kamani Podcast: https://www.web3pod.xyz/ KEY POINTS WITH TIMESTAMPS • [00:30] Introduction to Pasha from Igra Labs and what the episode covers• [01:51] Pasha's backstory , from Delivery Hero and Auto One to falling into crypto in 2017• [03:24] The core problem Igra Labs is solving: bringing EVM to proof of work via the Kaspa BlockDAG• [05:53] Why proof of work still makes sense , decentralization, security, and hardware commitment• [07:47] MEV resilience and front-run resistance as the killer property of EVM on proof of work• [09:44] Real use cases: stablecoins, DeFi, RWAs, and AI agentic settlement on Igra• [12:39] How EVM makes it easy for developers , Solidity tooling, SDKs, and AI coding agents• [14:26] Developer onboarding in minutes using a single GitBook link and an AI agent• [16:26] Introducing Multitude , sovereign execution zones allowing teams to launch their own Igra• [18:52] How Multitude differs from parachains, appchains, and L2 models like OpStack• [21:25] Where Web3 goes next , AI agents as the UX layer that finally unlocks mass adoption• [24:48] An agentic marketplace being built on Igra , like Upwork, but for AI agents• [27:02] What Pasha would do differently if starting Igra Labs today• [27:52] Current asks: design partners for Multitude, a small strategic round, and ambitious buildersDISCLAIMERNothing mentioned in this podcast is investment advice and please do your own research. It would mean a lot if you can leave a review of this podcast on Apple Podcasts or Spotify and share this podcast with a friend. Be a guest on the podcast or contact us - ⁠https://www.web3pod.xyz/

Short summary of two to three sentences here - this is what will get fed to Spotify and Apple Podcasts as episode description

How quickly can you improve your gut health? Can diet help lower your risk of dementia? And what should you know about food labels and healthy weight loss? In this special live Q&A, Prof Tim Spector, Prof Sarah Berry and Dr Federica Amati answer your biggest nutrition questions and share practical, evidence-based advice you can use today. Drawing on decades of research and data from hundreds of thousands of people, they explain how diet can influence the gut microbiome, brain health, hunger, energy levels and long-term health. They discuss dementia risk, healthy snacking, intermittent fasting, ultra-processed foods, plant diversity, breakfast, food labels and the latest science on weight loss. You'll learn how quickly the gut microbiome may respond to dietary change, why some foods keep you fuller for longer, how to build a healthier breakfast, and simple ways to make better food choices. The team also explain why small dietary changes can have lasting benefits. If your daily food choices influence your gut health, brain health and future wellbeing, which change is worth making first?

Phishing-resistant MFA could have stopped a Chinese state-sponsored threat actor from spending over a year inside North American academic and medical research networks — and we're going to tell you exactly how it happened and what you need to do about it.A group called UNC5608, tracked by Google's Threat Intelligence Group (GTIG), exploited a vulnerability unique to REDCap — a research data platform that allows multiple software versions to run simultaneously. They got in via stolen admin credentials, planted custom malware called Infinite.red directly into REDCap's upgrade process, harvested credentials for over a year, then used those credentials to log into Google Workspace as a domain admin and create fake compliance rules to silently forward sensitive research emails — military strategy, geostrategic policy, advanced tech, specific pathogens — straight to Gmail accounts they controlled. And nobody noticed for a very long time.Prasanna and I break down the full attack chain, then walk through every prevention layer that could have stopped it: inventory management, patching, password hygiene, SSO, phishing-resistant MFA, passkeys, DBSC, context-aware access, compliance rule monitoring, credential separation across security domains, and logging. We also get into what backups can and can't do for you in a long-dwell-time attack like this — and why infrastructure-as-code and truly immutable golden images matter more than you might think.If you're running any kind of research platform, academic institution, or medical network — or honestly any organization that uses Google Workspace — this one's for you.Chapters:00:00 — Intro: The attack that phishing-resistant MFA could have stopped01:03 — Show intro & woodworking banter03:26 — What is a living-off-the-land attack?04:02 — Who is UNC5608 and who did they target?05:08 — How REDCap's multi-version design was exploited06:11 — Infinite.red malware and credential harvesting09:01 — Google Workspace infiltration via fake compliance rules10:18 — The keywords they were stealing: pathogens, military strategy, and more11:50 — What could the victims have done differently?12:42 — Inventory management, patching, and legacy version removal14:00 — Why you can't trust application-level authentication alone — use SSO15:18 — Phishing-resistant MFA and why it matters16:00 — Passkeys, FIDO, and why there are zero known attacks against them17:57 — Device-bound session credentials (DBSC) and context-aware access19:38 — Monitor your compliance rules — have a compliance rule for the compliance rule20:40 — Credential separation across security domains23:00 — Get some logging — XDR, SIEM, and catching exfiltration in progress24:00 — What can backups actually do in a long-dwell-time attack?27:00 — Infrastructure-as-code and the right cyber recovery approach28:58 — Protecting your golden images with immutable storage31:59 — Wrap-up

When a family member chooses to live an isolated life, it can be incredibly difficult to know when—and how—to step in. It becomes even more challenging when that loved one flatly refuses medical help, hides their symptoms, or is dealing with cognitive decline.

Send us Fan MailTyler delivers the news and shares a zinnia story plus a final Hort Report. Adam Chapman and Sara Bates fill in from Saturday. Learn about deer resistant plants, meyer lemon issues, and edible squash blossoms. Support the show

Fresh Pressed Olive Oil Club (buy 2 get 1 free):https://freshpressolive.com/3SsENmd  Pre-order Keto Flex Revised and get free bonuses at: https://bit.ly/4wKG1sM    You're Taking Olive Oil WRONG: The Five Mistakes That Keep You Insulin Resistant With Ben Azadi Researchers have found that some olive oils contain up to 250 times more of the compounds that improve insulin sensitivity than others. Two people could take a tablespoon every day. One gets the documented benefits. The other gets almost nothing. In this episode, Ben breaks down the five mistakes that keep people from getting any real benefit from olive oil, including the one most commonly overlooked: inconsistent dosing. He also walks through the science behind a 22% reduction in diabetes risk, a 40% lower rate of developing diabetes from the PREDIMED trial, and why the throat sting you feel from a quality olive oil is working on the same anti-inflammatory pathway as ibuprofen. The bottom line is this: stubborn belly fat is not a calorie problem. It's a signaling problem. And the right olive oil, used the right way, every day, is one of the simplest places to start fixing the signal. Key Takeaways: Two people can take olive oil daily and get completely different results because polyphenol content varies by up to 250x Olive oil's benefits don't come from the fat itself, they come from polyphenol compounds that behave more like a supplement than a cooking oil The PREDIMED trial found a 30% lower rate of heart attacks and up to a 40% lower rate of diabetes from daily extra virgin olive oil use 69% of imported extra virgin olive oil tested in a UC Davis study failed to meet international quality standards The peppery throat sting in high-quality olive oil is oleocanthal, which blocks the same inflammatory enzymes as ibuprofen Olive oil does not break a fast because it does not raise glucose or insulin The five-step protocol: 1 to 2 tablespoons daily, raw, with food, stored correctly, checked for sting Find All The Ben Azadi Show Sponsorship Deals ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.ketokamp.com/sponsorship-deals Learn more about your ad choices. Visit megaphone.fm/adchoices

In this Corn Special Series episode of The Crop Science Podcast Show, Dr. Kevin Bradley, Professor and State Extension Weed Scientist at the University of Missouri, discusses practical strategies for managing herbicide-resistant weeds in corn and soybean systems. He shares insights on waterhemp, cover crop biomass, harvest weed seed control, electrocution technology, precision spraying, and why residual herbicides still matter. Listen now on all major platforms!"Herbicide resistance continues forcing major changes in weed management programs across corn and soybean systems, especially with waterhemp and Palmer amaranth spreading rapidly."Meet the guest: Dr. Kevin Bradley is a Professor and State Extension Weed Scientist in the Division of Plant Science and Technology at the University of Missouri. His extension and research work focuses on applied weed management in corn, soybean, and forage systems, with extensive work on herbicide-resistant waterhemp. He earned his PhD from Virginia Tech and has served at the University of Missouri since 2003. Listen to The Crop Science Podcast Show with Dr. Kevin Bradley on all major platforms.Liked this one? Don't stop now — Here's what we think you'll love!What you will learn:(00:00) Highlight(00:59) Introduction(05:00) Herbicide resistance trends(06:02) Cover crops(07:37) Harvest seed control(15:33) Weed electrocution(21:30) Precision spraying(25:25) Final questionsThe Crop Science Podcast Show is trusted and supported by innovative companies like:- Loam Bio

This Day in Legal History: Kennedy Signs the Equal Pay ActOn this day in 1963, President John F. Kennedy signed the Equal Pay Act, the first federal statute aimed directly at sex-based wage discrimination. The law took the form of an amendment to the Fair Labor Standards Act of 1938, which meant that it slid into an existing enforcement framework run by the Wage and Hour Division of the Department of Labor — a deliberate choice that bypassed the need to build new institutional machinery and harnessed thirty years of FLSA caselaw and habits of compliance. The legal hook is the Act's “equal pay for equal work” command: employers may not pay employees of one sex less than employees of the opposite sex for jobs requiring “equal skill, effort, and responsibility, and which are performed under similar working conditions.”Four affirmative defenses are written into the text — a seniority system, a merit system, a system measuring earnings by quantity or quality of production, or “any other factor other than sex” — and that fourth catch-all has done more work in litigation than the other three combined, shaping how courts evaluate market-based, education-based, and prior-salary-based pay differentials decades later. The wage gap at the moment Kennedy signed was about 59 cents on the dollar; six decades on, by the Bureau of Labor Statistics's standard measure, it sits closer to 84 cents. That tells you something about how a clean, structurally well-designed statute can still leave a lot of the work undone, because the gap is and always was about more than identical pairs of jobs at the same employer.The Equal Pay Act is not the whole story of American workplace-equality law; Title VII of the Civil Rights Act of 1964, the Pregnancy Discrimination Act, the Lilly Ledbetter Fair Pay Act, and a long line of state-law analogues do much of the modern enforcement work. But June 10, 1963 is the day Congress, with the President's signature, said for the first time that paying a woman less than a man for the same work was unlawful, full stop. Everything that has followed in this corner of the law has been built on top of that sentence.The Federal Circuit on Monday affirmed a Delaware district court judgment invalidating four Purdue Pharma patents covering an abuse-deterrent, low-toxicity version of the opioid OxyContin, in a decision the patent bar has been waiting on for months. The case is Purdue Pharma L.P. v. Epic Pharma LLC. The patents covered Purdue's reformulation of OxyContin to make the pills crush-resistant and to reduce a manufacturing impurity, and the asserted innovation grew, the company said, out of its discovery of the source of a particular toxic impurity that had previously eluded chemists at competing labs. Purdue's argument on appeal was, in essence, that the discovery of the impurity's source was itself nonobvious, and that the resulting patents inherited that nonobviousness. The Federal Circuit said no.The panel held that the relevant obviousness inquiry asks whether the claimed reformulation — not the discovery that motivated it — would have been obvious to a person of ordinary skill in the art at the time of the invention, and that once the prior art is taken into account, the answer is yes. The practical consequence of the ruling is large. It opens the door wider for generic abuse-deterrent OxyContin alternatives and clarifies a doctrinal point pharmaceutical companies have been pressing on for years: a hard-won research insight does not, on its own, automatically save a patent from obviousness if the resulting product was within the prior art's reach. Purdue's options now are a rehearing petition at the Federal Circuit, a cert petition at the Supreme Court (which the company has already pursued in a related case last spring), or quiet acceptance. Expect a cert petition. Expect the cert petition to be denied. Watch the generic-drug filings that follow.Fed. Circ. Panel Backs Invalidation Of OxyContin PatentThe plaintiffs in the Eastern District of Virginia lawsuit over the Trump administration's $1.8 billion “Anti-Weaponization Fund” — a story we covered earlier htis week— went back to Judge Leonie Brinkema on Tuesday and asked for permission to conduct limited discovery into whether the Justice Department's recent representation that it would stop work on the fund is a real commitment or a litigation convenience.The plaintiffs' problem is straightforward: acting Attorney General Todd Blanche has filed papers saying the program is “not going forward,” but President Trump publicly described the fund last week as a “great idea” that many Republicans support, and the executive order that created the fund has not been formally rescinded. From a litigation-strategy standpoint, the plaintiffs do not want to walk away from a live case on the strength of a DOJ filing, accept dismissal as moot, and then find out three months later that the fund has been quietly resurrected under a different name.Judge Brinkema has a hearing scheduled for Friday, June 12, on whether to extend the temporary restraining order into a preliminary injunction. The Tuesday filing teed up the broader mootness fight that will dominate Friday's hearing: when does a federal agency's promise to stop doing something actually deprive a court of jurisdiction to enjoin the underlying program, and what discovery, if any, is a plaintiff entitled to before that determination is made. The doctrine here — voluntary cessation, capable of repetition yet evading review, and the heavy burden the Supreme Court has placed on the party claiming mootness — favors the plaintiffs procedurally. Whether Brinkema agrees on Friday is the question to watch.‘Anti-weaponization' fund challengers question its demise – Roll CallSCOTUSblog's John Elwood walked through a useful relist roundup on Tuesday, and the four cases sitting in the relist pile are worth flagging because each of them touches a different load-bearing wall in federal practice. The first is a prolonged-detention challenge to immigration custody under Section 1226(c). The ACLU is asking the Court to clarify that very long mandatory-detention periods trigger procedural due process review under the Mathews v. Eldridge balancing test, picking up on the Second Circuit's willingness to do so. The second is Newberry v. Texas, a case where Texas itself has confessed error — a rare procedural posture in which the State agrees the defendant should win — and the question is what the Court does when the parties on both sides ask for the same remedy. The third is Kian v. Florida, a Sixth Amendment challenge to the use of six-person juries in serious felony cases, on the theory that the historical understanding of “jury” in the founding era assumed twelve and that the Court's mid-twentieth-century cases approving six-person juries were wrong on the originalist analysis. The fourth is Maxwell v. Thomas, a federal habeas case asking whether the First Step Act‘s halfway-house and home-confinement provisions are properly enforceable through 28 U.S.C. § 2241 habeas petitions, an issue with a real circuit split. None of these have been granted yet — they are relists, which means at least one Justice is interested but the Court has not yet decided whether to hear them — but the mix is the part to watch: it tells you what the Justices are circling without committing to. Expect at least one of these to be granted before the term ends.A random assortment of relists: prolonged detention, confessions of error, small juries, and new rules on habeas | SCOTUSblog This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.minimumcomp.com/subscribe

Founder and self-described "agentic power broker" Charles Cormier on why human relationships are the one moat AGI can't cross, how to use a podcast as your B2B funnel, and why comfort is death.

What plants will weather a hot, dry summer best? Our BC Today gardening columnist Brian Minter offers planting advice and takes audience calls.

In a YUGE episode Sophie, Lleyton and Peter go through it all:

Drug-resistant infections are a major public health threat around the world. To fight them, scientists are constantly trying to find and develop new antibiotics. Now, researchers say artificial intelligence is helping speed their search. Miles O'Brien reports. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

“Hyloom” tomato varieties have become popular with growers for the combination of heirloom flavor and looks, and grower-friendly traits like improved vigor and disease resistance. In this interview we talk with Greg Vogel, Assistant Professor of Plant Breeding and Genetics at Cornell University, who is working on breeding hyloom tomato varieties. If you're a tomato nerd you're in luck because we go deep on them in this interview. We talk about what makes an heirloom, what makes a hyloom and the traditional breeding practices that allow any farmer to try their hand at making one. We also talk about how they try to breed new hyloom varieties strategically so they outperform their parents. In the process we cover the genetic basis of a lot of things you might have noticed in the field, like why long-fruited tomatoes tend to get more blossom end rot, why heirlooms tend to have more defects like zippering and catfacing, why there tend to be more of those defects at the beginning and end of the season, and lots of other tomato nerdery! Connect With Guest: Website: https://cals.cornell.edu/people/greg-vogel Podcast Sponsors: Huge thanks to our podcast sponsors as they make this podcast FREE to everyone with their generous support: Tilth Soil makes living soils for organic growers. The base for all our mixes is NOP-compliant compost, made from the 4,000 tons of food scraps we divert from landfills each year. And the results speak for themselves. Get excellent germination, strong transplants, and help us turn these resources back into food. Try a free bag and learn more at tilthsoil.com/gfm. Nifty Hoops builds complete gothic high tunnels that are easy to install and built to last.  Their bolt-together construction makes setup straightforward and efficient, whether it's a small backyard hoophouse, or a dozen large production-scale high tunnels- especially through their community build option, where professional builders work alongside your crew, family, or neighbors to build each structure -- usually in a single day.Visit niftyhoops.com to learn more. Farming is hard. Running it shouldn't be. Tend helps you plan your season, map your farm, and track every task from seed to sale. No spreadsheets, no guesswork, just seamless workflows. Tend is the all-in-one farm management platform that brings together planning, field mapping, fulfillment, real-time inventory, sales, labor, traceability, and accounting in one easy platform. Built for small market gardens, CSAs, and large diversified farms. Get started with a free account at Tend.com. No credit card required. Seven Springs Farm Supply is a farm-based supply company focused on serving market gardeners and has been in business for 35 years. Their catalog includes a comprehensive selection of approved-for-organic fertilizers, pest & disease controls, growing mixes, cover crop seed, and more. They offer custom fertilizer blending and seasonal cooperative purchasing opportunities, and their experienced team is ready to help guide you to the best solution for your farm's needs. Growing For Market listeners are eligible for an exclusive discount. Visit 7springsfarm.com/GFM or give them a call at (540) 651-3228. If you grow for market, you know performance is everything. That's why so many farmers are turning to Burpee's Farmers Market. Dedicated to professional growers, Burpee is now offering non-GMO seeds in larger quantities – bred and selected for standout flavor, strong yields, and the kind of visual appeal your customers crave. Burpee's been doing this for 150 years, and they're still creating new varieties with growers like you in mind. You can check out the full lineup at Burpee.com/FarmersMarket. There are a lot of farm sales platforms out there, but there's only one that's cooperatively owned by farmers. That's GrownBy — your all-in-one solution to simplify farm sales. GrownBy makes online farm sales easy and affordable; setting up your shop is free, and you only pay when you sell. Join over 900 farms who have already signed up for GrownBy, at grownby.com. For more on veg and flower market farming, subscribe to Growing for Market Magazine!

Kristina Cook shares how lifelong anxiety and postpartum depression, combined with her daughter Genevieve's escalating, unpredictable mood instability, rage, suicidality, and mania, pushed their family into crisis despite years of therapy, medications, and an 11-year-old's 16-week hospital in-treatment stay with a discharge plan involving notifying police. After an RFK Jr. press conference led her to Casey and Calley Means' message in Good Energy, Kristina removed ultra-processed foods and refined ingredients and saw rapid improvements in sleep, pain, and her daughter's behavior. Later, after hearing Dr. Chris Palmer describe ketogenic therapy for severe mental illness, Kristina and her daughter transitioned to keto, endured a brief detox period, and then experienced dramatic mental clarity; Genevieve reached remission and came off medication, and Kristina also saw major weight and anxiety relief. Kristina now studies nutrition, works with the Metabolic Collective, and advocates for accessible metabolic therapies for families. Good Energy (book by Casey Means & Callie Means)  metaboliccollective.org  Metabolic Mind — https://www.metabolicmind.org/ Kristina on X (Twitter): @KristinaCook https://x.com/KristinaCo9561 The Better Humans Project — Kristina's Instagram and Facebook pages  https://www.instagram.com/thebetterhumansproject?igsh=MTM4YTkyZ3duejdjbw==

Mycorrhizal fungi expand plant root surface area hundreds of times, unlocking drought resistance and boosting nutrient uptake. This episode covers the science behind this underground partnership and the inoculation methods professional growers rely on. Read more at https://humko.eu/ HUMKO, d.o.o., Bled City: Podnart Address: Podnart 33a Website: https://humko.eu/

Today we talk with Rachel Miner, founder of Bellwether International, and Jennie Lloyd, Board Chair of Utah Global Diplomacy, about how to promote peace in our communities.

Do you focus on and are you grateful for God's Goodness, Forbearance, and Longsuffering towards you in your life?

Featuring a slide presentation and related discussion from Dr Wassim Abida, including the following topics: Clinical implications of homologous recombination repair gene alterations and biological rationale for the use of PARP inhibitors (0:00) Key clinical studies leading to FDA approvals of PARP inhibitors as monotherapy (5:01) Biological rationale for combining PARP inhibitors with androgen receptor pathway inhibitors and key findings from the Phase III PROpel study (11:03) Key findings from the Phase III MAGNITUDE and TALAPRO-2 studies (15:10) Summary of efficacy data with PARP inhibitors; toxicities (20:01) Key findings and conclusions from the Phase III AMPLITUDE study; future directions with PARP inhibitors (23:33) CME information and select publications

Featuring an interview with Dr Wassim Abida, including the following topics: Comparing the clinical relevance of BRCA1 and BRCA2 mutations in prostate cancer (0:00) Relevance and interpretation of LOH (loss of heterozygosity) scores (4:37) Incidence and clinical relevance of PALB2 mutations; role of genetic counseling in the care of patients with prostate cancer (9:33) Key considerations surrounding toxicities associated with PARP inhibitors (15:25) Potential role of saruparib; evolving nomenclature in prostate cancer (22:36) Approach to newly diagnosed metastatic prostate cancer (26:16) Clinical relevance of PSMA-targeted PET imaging results (29:49) Case: A man in his mid 70s with metastatic castration-resistant prostate cancer (mCRPC) and a deleterious BRCA alteration receives olaparib/abiraterone/prednisone upon relapse (32:15) Combining PARP inhibitors with other DNA repair inhibitors; insights on the PSMAddition trial (37:14) Case: A man in his mid 60s with metastatic prostate adenocarcinoma and a BRCA germline mutation receives niraparib/abiraterone/prednisone (43:17) Case: A man in his early 60s with mCRPC and CDK12 mutations receives talazoparib/enzalutamide (45:54) CME information and select publications

How can you lift weights, build muscle, and still be insulin resistant? What if your metabolism is sending warning signs before your A1C ever changes?Insulin resistance is often treated like a weight loss or carb problem, but Amber Wilhoit, a registered dietitian and diabetes specialist with 22 years of clinical experience, shows why muscle quality, visceral fat, fiber, sleep, stress, and daily movement all matter.We talk about fasting insulin, waist-to-hip ratio, post-meal walks, strength training, and why midlife hormone health can shift body composition even when your effort stays the same. You'll learn how to lose fat, build muscle, and protect your metabolism with evidence-based nutrition and fitness strategies that go beyond “just lift more.”Join Eat More Lift Heavy, the 26-week fat loss program for adults over 40 where you learn the skills to improve your insulin sensitivity, build muscle, eat a flexible diet full of protein and carbs, and improve your sleep, stress, and movement... one week at a time so it's sustainable and you FINALLY keep the fat off for good.Timestamps:0:00 - Why muscle may not fix insulin2:39 - Visceral fat and waist-to-hip6:26 - Fasting insulin, the underused test10:06 - Exercise pathways, stress, and sleep18:52 - Protecting muscle during fat loss21:08 - Perimenopause shifts and visceral gain26:53 - Stop over-restricting nutrition34:28 - Sexual health as metabolic signal39:04 - Fiber, gut health, and glucose controlEpisode resources:Website: Empowered Diabetes Podcast: The Diabetes Podcast®YouTube: @TheDiabetesPodcast Instagram: @empowereddiabetes 

Dr. John Fleetham speaks with Dr. Leonardo Martinez about his article, "The Effectiveness of Isoniazid Preventive Treatment Among Contacts of Multidrug-Resistant Tuberculosis: A Systematic Review and Individual-Participant Meta-Analysis."

Denise M O'Sullivan, Gerwyn M Jones, Manca Zolnir-Dovc, Richard Phillips, Rejoice Arthur, Bariki Mtafya, Daniel Adon Mapamba, Daniela Maria Cirillo, Ewa Augustynowicz-Kopeć, Mei Mei Ho, Belinda Dagg, Sven O Friedrich, Francesca Colavita, Antonella Vulcano, Prince Asare, Dorothy Yeboah-Manu, Timothy D McHugh, Jim F Huggett. Methods to Improve Confidence in the Accuracy of Molecular Testing for Multidrug-Resistant Tuberculosis. Clinical Chemistry, Volume 72, Issue 3, March 2026, Pages 390–397. https://doi.org/10.1093/clinchem/hvaf178

In this episode of Beekeeping Today Podcast, Jeff Ott and Becky Masterman continue their queen-focused spring series with longtime beekeeper, researcher, and educator Randy Oliver and commercial beekeeper Eric Oliver. The conversation explores the realities of large-scale selective breeding for Varroa-resistant honey bees and the development of the Golden West queen line. Randy explains how his operation shifted toward breeding for mite resistance after discovering a colony in 2015 that consistently maintained zero Varroa counts without treatment. That colony became "Queen Zero," launching a years-long selective breeding effort focused on resistance, gentleness, and honey production. Eric discusses how the operation evolved from occasional mite sampling into full-operation mite washing programs involving thousands of colonies, streamlined systems, and detailed tracking methods. The discussion covers the importance of drone saturation, isolated mating yards, and why successful breeding programs require cooperation among large groups of beekeepers. Randy and Eric explain their partnership with Olivarez Honey Bees to scale Golden West queen production while preserving genetic consistency through controlled mating environments. Jeff and Becky also discuss how healthier bees change the overall beekeeping experience, from colony management and overwintering to reduced chemical inputs and calmer hive behavior. Randy shares his views on breeding for gentleness, avoiding "Frankenbee" genetics, and why maintaining a stable breeding population is essential for long-term progress against Varroa mites. The episode also includes a listener question from Anne Bettencourt about how long beginning beekeepers should keep colonies open during inspections, leading to a thoughtful discussion on balancing learning opportunities with colony health and productivity. Websites from the episode and others we recommend: Scientific Beekeeping: https://scientificbeekeeping.com Olivarez Honey Bees: https://www.ohbees.com/ Honey Bee Health Coalition: https://honeybeehealthcoalition.org Project Apis m. (PAm): https://www.projectapism.org The National Honey Board: https://honey.com Honey Bee Obscura Podcast: https://honeybeeobscura.com   Copyright © 2026 by Growing Planet Media, LLC     ______________ Betterbee is the presenting sponsor of Beekeeping Today Podcast. Betterbee's mission is to support every beekeeper with excellent customer service, continued education and quality equipment. From their colorful and informative catalog to their support of beekeeper educational activities, including this podcast series, Betterbee truly is Beekeepers Serving Beekeepers. See for yourself at www.betterbee.com This episode is brought to you by Global Patties! Global offers a variety of standard and custom patties. Visit them today at http://globalpatties.com and let them know you appreciate them sponsoring this episode!  As a beekeeper, you want products that benefit you and your bees. When you choose Premier Bee Products, you choose hive components that are healthier for bees and more productive for you. Because we believe that in beekeeping, details make all the difference. Premier Bee Products: Better for bees. Better for beekeepers. Use promo code PODCAST for 10% off your next online order. APIS Tactical is a beekeeping brand focused on innovation. We create a wide range of gear for beekeepers of all types—whether you're managing a few hives or working bees every day. We combine science and artistry to create purposeful, hardworking gear. We're here to help you care for your bees with confidence, so you can focus on what matters most—your hive. Thanks to Strong Microbials for their support of Beekeeping Today Podcast. Find out more about their line of probiotics in our Season 3, Episode 12 episode and from their website: https://www.strongmicrobials.com HiveIQ is revolutionizing the way beekeepers manage their colonies with innovative, insulated hive systems designed for maximum colony health and efficiency. Their hives maintain stable temperatures year-round, reduce stress on the bees, and are built to last using durable, lightweight materials. Whether you're managing two hives or two hundred, HiveIQ's smart design helps your bees thrive while saving you time and effort. Learn more at HiveIQ.com. We'd like to thank Vita Bee Health for supporting the podcast. Vita provides proven tools for controlling Varroa—from Apistan and Apiguard to the new VarroxSan extended-release oxalic acid strips—helping beekeepers keep stronger, healthier colonies. Thanks for Northern Bee Books for their support. Northern Bee Books is the publisher of bee books available worldwide from their website or from Amazon and bookstores everywhere. They are also the publishers of The Beekeepers Quarterly and Natural Bee Husbandry. _______________ We hope you enjoy this podcast and welcome your questions and comments in the show notes of this episode or: questions@beekeepingtodaypodcast.com Thank you for listening!  Podcast music: Be Strong by Young Presidents; Epilogue by Musicalman; Faraday by BeGun; Walking in Paris by Studio Le Bus; A Fresh New Start by Pete Morse; Wedding Day by Boomer; Christmas Avenue by Immersive Music; Red Jack Blues by Daniel Hart; Bolero de la Fontero  by Rimsky Music; Perfect Sky by Graceful Movement; I'm Not Running Away This Time by Max Brodie; Original guitar background instrumental by Jeff Ott. Beekeeping Today Podcast is an audio production of Growing Planet Media, LLC ** As an Amazon Associate, we may earn a commission from qualifying purchases Copyright © 2026 by Growing Planet Media, LLC

Klebsiella - A Multidrug-Resistant Bacteria by The Venting Machine

If you’ve ever typed “am I homeschooling my child the right way” into a search bar at 11pm — this post is for you. Most homeschool moms have experienced some version of that same question — am I homeschooling my child the right way? — and most of them are asking it for exactly the right reasons. Not out loud, necessarily. More likely, as a quiet voice at the end of the day, after the books are closed and the planner is put away. Here’s the truth: there is no single “right way” to homeschool your child. But there is something that works — and it’s more accessible than you think. Am I Homeschooling My Child the Right Way? (& Why the “Right Way” to Homeschool Is a Myth Worth Busting) The homeschool world has a way of making moms feel like there’s a correct answer they haven’t found yet. The right curriculum, the right schedule, and the right philosophy. Classical or Charlotte Mason. Structured or unschooling.90 minutes a day or seven hours? And so the search begins — and the second-guessing never quite stops. Every mom who has ever asked “am I homeschooling my child the right way” deserves a better answer than another curriculum or method recommendation. Here’s what I’ve noticed after many conversations with homeschool moms who are deep in this: the ones who feel most lost are rarely the ones doing it wrong. They’re the ones paying close enough attention to notice the gap between what they planned and what their child actually needs. That gap isn’t failure. It’s information. The “Right Way” Is a Moving Target — And That’s Actually Good News The truth about homeschooling the “right way” is that right was never a fixed destination. It’s a moving target — and it moves because your child moves. She grows, shifts, changes her mind, surprises you. The mom who is asking am I getting this right? is almost always the mom who is watching closely enough to ask better questions. What “Right” Actually Means for Your Child Let me tell you about a mom I’ll call Joni. Joni had done everything by the book. Researched curricula for months. Built a beautiful schedule. Joined a co-op. Colour-coded her planner. By any external measure, she was homeschooling the “right way.” And yet her daughter — bright, curious, twelve years old — was disengaged. Resistant. Going through the motions, most of the time, so she could put her books back in her designated basket so she could run off and play. Joni kept adjusting the external pieces. Different workbooks. Different incentives beyond playtime or screentime. She offered her daughter more flexibility. Less flexibility. The result was always the same. Not the daughter she’d hoped to homeschool. Not the child the curriculum would work for. The specific, real, living girl in front of her — with her own interests, her own learning rhythms, her own quiet signals about what was and wasn’t working. The Question Underneath the Question That shift — from am I following the right method? to is this right for this child? — was where freedom lived. If you’d rather listen than read — or you want to share this conversation with a homeschool mom you know — I’ve covered all of this in this week’s podcast episode too. Press play below. https://youtu.be/ICLwWbL_9Uc?si=mfVtMHFoSfTdfYhf Am I Homeschooling My Child the Right Way? A Framework for Making Decisions You Can Trust After many conversations like the one I had with Joni, I built something I call the Right-for-This-Child Framework — six questions designed not to grade your homeschool, but to help you think with your child instead of about her. It’s not a lens into the reality of your homeschool kiddo and your homeschool plans. Here are two of the six questions, because they tend to be where the most immediate relief lives when you’re wondering if you’re homeschooling your child the right way: “Does this approach honour who she is right now?” Not who she was six months ago. Not who you’re hoping she’ll grow into. Who she is today — her interests, her energy, her actual learning preferences. This sounds obvious until you realize how often we design our homeschool around a future version of our child who doesn’t quite exist yet. The more focused, more compliant, more grateful version. Or even the child that doesn’t exist. And I’ll add that sometimes we’re trying to build a homeschool around the “child” that is within you! You might be, like me, trying to build a homeschool you would LOVE at age 28-54;) Meanwhile, the real child in front of us is sending signals we’re too busy adjusting the plan to receive. Observing your child’s energy — not just her output — is data. When she lights up, that’s data. When she goes quiet in a particular way, that’s data. Small, genuine check-ins about how she’s experiencing things give you more useful information than any progress tracker. “Am I reacting out of fear right now — or out of clarity?” This one requires self-awareness. So much of what looks like a homeschool problem is actually a mom’s nervous system problem. When a child resists or stalls, it can activate something old — a fear about falling behind, about not being enough, about her future narrowing in some irreversible way. From that place, we tend to push harder, control more, and inadvertently make the resistance worse. The practice is simple but not easy: pause before you respond. Five or ten minutes. Journal a sentence. Let the reactive emotional wave pass. What’s left after the pause is almost always much closer to your actual wisdom. The Other Four Questions (And What They Cover) The full framework goes further — into aligning decisions with your core values, weighing short-term discomfort against long-term growth, building flexibility into your plans rather than demanding perfection, and creating a simple weekly rhythm of reflection and recalibration. Together they give you a repeatable way to move through doubt. Not by eliminating it — but by using it as a starting point rather than a stopping point. The real answer to “am I homeschooling my child the right way” is never yes or no. It’s: are you paying attention, staying curious, and adjusting as you learn? If yes — you’re doing it right. The Doubt Is Not the Actually the Problem Joni didn’t need a new curriculum. She needed permission to trust what she already knew about her daughter — and a structure to help her hear herself think. If you’re in that place right now — doing the work, carrying the worry, wondering if anyone else feels this too — I want you to say this out loud: The fact that I’m asking this question means I’m the right person for this. Say that sentence again. And again. Remember that “bad homeschool moms” don’t lie awake wondering if they’re getting it right. The negligent homeschool moms aren’t googling “am I homeschool my child the right way” at midnight? (ps If I’m right and YOU are googling those words and that’s why you found me, drop me a comment below, I’d love to hear!) If you’d like support figuring out what “right for this child” actually looks like in your specific home, with your specific kid — that’s exactly the kind of conversation I’m here for. Start there. The rest tends to follow. Free Resources to Help You Homeschool With Confidence You’ve made it this far in this post because something here resonated. Maybe it was the question you’ve been carrying quietly. Or maybe it was Joni’s story. Maybe it was simply the relief of someone finally saying there is no single right way. Whatever brought you here — whether you googled “am I homeschooling my child the right way” or stumbled in through a friend’s share — I don’t want you to leave empty-handed. Depending on where you are in your homeschool journey, I’ve created something specific for you. Take the one that fits. For First-Year Homeschool Moms: The Confident Homeschool Roadmap Starting your homeschool journey is one of the bravest things a mom can do — and one of the most disorienting. You pulled your child out of traditional school (or never put them in) because you believed there was something better. And now you’re staring at a blank calendar wondering where to begin. The Confident Homeschool Roadmap is your starting point. It walks you through the foundational decisions every new homeschool mom needs to make — in the right order, without the overwhelm — so you can stop spinning and start building something that actually fits your child and your family. Inside you’ll find a clear sequence for getting started, questions that help you define what you want homeschooling to look like, and a simple structure that creates confidence without locking you into someone else’s method. When you download the Roadmap, you’ll also receive the Purposeful Homeschool Mom Weekly newsletter — a short, grounding note each week with practical encouragement, honest reflections, and tools to help you keep trusting yourself through every stage of this journey. → Grab Your Free Confident Homeschool Roadmap Download your 1st Year Confident Homeschool Roadmap For Moms Who’ve Been At It a While: The Deschool Your Homeschool Checklist You homeschool to give your child something better. So why does it still feel like you’re just recreating school at home? Your child resists anything that looks like “school.” You’re stuck somewhere between structure and freedom, second-guessing every decision, and quietly wondering if you’re doing it wrong. Here’s the truth: you’re not doing it wrong. You just haven’t deschooled yet. Or maybe you need to deschool deeper or for a new season of your family life. Deschooling is the most commonly skipped step in homeschooling — and the one that makes a ginormous difference. It’s the process of letting go of traditional school thinking so you can build something that actually fits your child, your values, and your real life. What You’ll Work Through Inside the Checklist The Deschool Your Homeschool Checklist is your reset button. It’s a free, simple guide that helps you: Step back from school-y mindsets that are quietly running the show Reconnect with how your child actually learns — not how school said she should Create space for curiosity, calm, and genuine connection Set a new course with intention and clarity Inside you’ll work through seven foundational shifts: observing your child’s natural interests, noticing what genuinely sparks their excitement, understanding their real learning style, examining the rhythms of your family relationships, getting curious about boredom instead of fixing it, defining your own version of education, and embracing the gaps instead of fighting them. When you download the Checklist, you’ll also be joining the Purposeful Homeschool Mom Weekly newsletter — where each week I share honest encouragement, practical tools, and gentle reminders that you are more capable of this than you think. → Download the Free Deschool Your Homeschool Checklist

If you're ready to get off of struggle island...click here!

In this episode of THE ICHE Podcast, host Dr. David Calfee is joined by two authors from the April 2026 issue of ICHE to discuss current infection control practices and ongoing challenges in preventing multidrug-resistant organisms and Candidozyma auris in U.S. acute care hospitals. During the conversation, Dr. KC Coffey and Dr. Sarah Sansom explain the rationale behind their studies, share key findings on current practices, and highlight the challenges hospitals face in their efforts to control transmission of these pathogens. Articles discussed: https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/current-infection-control-practices-for-multidrugresistant-organisms-mdro-a-survey-of-the-society-for-healthcare-epidemiology-of-america-shea-research-network-and-affiliated-usbased-hospitals/F6250FE7353AB4B56C4323CDC7EB7843 https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/candidozyma-auris-prevention-practices-in-the-united-states-insights-from-the-shea-research-network/681623BFF050669F472BB80F4DCB073F

In this master's class episode of the Smart Real Estate Coach Podcast, I sit down with Allen Lomax for a timely conversation on what high-income earners, retirees, and serious investors should be thinking about right now if they want to protect wealth, reduce tax drag, and build more recession-resistant income streams. Allen brings a unique lens to this because he has lived through the same kinds of market shocks many of us have, including the 2008 crash, and he now helps accredited investors reposition capital more intentionally through his Stream to Impact framework.     We talk about conditioning, why so many professionals cling to jobs and investment strategies that feel safe but are actually risky, and what it takes to move from compliance into alignment and eventually freedom. Allen breaks down why many high-income individuals are overexposed to public markets, how commercial real estate, oil and gas, and equipment-heavy businesses can create stronger tax advantages and lower correlation to Wall Street, and what kind of capital base can realistically help someone transition from working for money to having money work for them.    If you are building three paydays now and want to understand what the next level of wealth deployment can look like, this episode will open up a whole new conversation.   Key Talking Points of the Episode   00:00 Introduction 01:08 Who is Allen Lomax and why did we bring him back? 02:30 The story of Finn and recognizing life conditioning 04:13 The three stages: conditioning, alignment, and freedom 05:25 Lessons from the 2008 market crash 06:40 The shift from doing everything yourself to joining the right team 08:20 Becoming a capital raiser and working inside family-office structures 10:12 Breaking free from the J.O.B. security blanket 11:05 The 3 Paydays System 13:33 Strategies for accredited and high-income investors 16:05 Unlocking high returns and passive income timelines 17:10 Tax liability reduction and asset depreciation strategies 18:55 Non-correlating assets and recession resistance 20:13 Analyzing sector stability: multifamily, storage, and car washes 22:01 Evaluating upstream and midstream operators 24:22 How to get in touch with Allen and his team   Quotables   "Many of us move through really three stages from conditioning… then we can find alignment… and then eventually we can find our freedom."   "Hold on to that security blanket and find out, like I did, that it's not so secure."   "The bulk of the high-income individuals we're working with have anywhere from 85 to 95% of their capital in public markets. If that were me, I'd be getting it out of there pretty quickly."    Links   Episode 497: Why the Wealthy Avoid Stocks – And What They Invest in Instead with Dr. Allen Lomax https://podcasts.apple.com/us/podcast/episode-497-why-the-wealthy-avoid-stocks-and-what/id1266331428?i=1000697850727   3 Paydays® Live https://3paydayslive.com/podcast   Free Discovery Call https://smartrealestatecoachpodcast.com/discovery   3 Paydays® System Mastery Course - Use coupon code for 50% off https://smartrealestatecoach.com/qls Coupon code: pod   Apprentice Program https://3paydaysapprentice.com Coupon code: Podcast   Masterclass https://smartrealestatecoach.com/masterspodcast   3 Paydays Books https://3paydaysbooks.com/podcast   Partners https://smartrealestatecoach.com/podcastresources

In this episode of the Media BuzzMeter, Howie Kurtz is joined by former Congressman, Fox News contributor, & and host of the Jason in the House podcast,  Jason Chaffetz, for a candid look at the crumbling ceasefire with Iran and the impact of gas prices on the upcoming midterms. They discuss the President's reaction to media coverage and the math behind a potential Senate flip. The duo breaks down the stories dominating the headlines in 2026. "I think the president does have a strong point there... but people want to see gasoline that's $2 a gallon. That's ultimately what they want." — Jason Chaffetz on the political impact of the ongoing war. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Manufactured housing rarely gets attention until markets tighten. That's exactly why Matthias Gruenwald built a business around it. In this episode, Matthias, co-founder of WCG Investments, shares how he grew from a duplex in 2022 to overseeing roughly $45 million across 25 manufactured housing communities in less than three years. Before real estate, Matthias was a global manufacturing COO. He brought that same operational discipline into an asset class that rewards execution over hype. We break down why manufactured housing can be one of the most stable and misunderstood sectors in real estate. What We Cover How $60K–$80K homes solve the affordability gap The difference between park-owned homes and tenant-owned homes Why converting homes to tenant-owned dramatically lowers expense ratios How some parks run at 30–40% expense ratios Creative "handyman special" strategies to reduce CapEx Infill strategies that add new homes and boost NOI Why infrastructure matters more than curb appeal Sewer systems, lagoons, and what to avoid in due diligence Why tiny rural markets without job centers can stall growth Scaling from small parks to 280+ unit acquisitions Building in-house management for tighter operational control How AI is improving collections and reducing staffing overhead Matthias also shares how his automotive manufacturing background shaped his approach to reporting, metrics, and disciplined execution. If you want predictable cash flow, low operating volatility, and exposure to workforce housing demand, this episode lays out exactly how the model works. Connect with Matthias Gruenwald Website: https://wcginvestments.com Free Ebook on Manufactured Housing available on the website Instagram: Matthias Gruenwald Facebook: Matthias Gruenwald LinkedIn: Matthias Gruenwald Today's episode is brought to you by Green Property Management, managing everything from single family homes to apartment complexes in the West Michigan area. https://www.livegreenlocal.com And RCB & Associates, helping Michigan-based real estate investors and small business owners navigate the complex world of health insurance and medicare benefits. https://www.rcbassociatesllc.com

In this episode of SLP Coffee Talk, Hallie gets real about one of the biggest challenges with older students—resistance. From crossed arms to "I'm only here because my mom made me," she breaks down why grades 4–12 students push back in the first place—it's not laziness—and walks through five practical steps for building genuine buy-in. This episode is full of compassion-first strategies, reframable language, and low-prep activity ideas that actually meet students where they are.Bullet Points to Discuss: Why resistance in older students is self-protection, not defiance The three things a resistant student is almost always trying to communicate How to start a buy-in conversation—even when you only have 25 minutes Why "world" beats "school" when making goals feel relevant The shift from fixing to coaching, and why it changes everythingHere's what we learned: Resistance is information. Before you plan the activity, ask what they think they're there for. Students who've been in speech since early intervention are hyperaware of their difficulties—lead with compassion first. Tie your goals to their world: dating, jobs, group chats, driver's ed. Skip the school pitch. Let students have a say in how you work on a goal, even if they can't choose the goal itself. One activity can cover a million goals. Done and engaged beats perfect and checked out. Call yourself a language coach, not a speech teacher. The reframe matters more than you think. Buy-in is like charging a phone—you plug in consistently and watch the battery move.Learn more about Hallie Sherman and SLP Elevate:  

In this episode, Danielle breaks down one of the most overused phrases in women's health and weight loss: weight loss resistance. If you feel like you're doing everything right but not losing weight, or you're worried your metabolism or hormones are the problem, this episode is for you. Danielle gets honest about why most women are not actually dealing with true weight loss resistance, and what's really getting in the way of fat loss. She walks through the foundational habits that must be consistent before blaming your hormones, including strength training, calorie intake, daily movement, and protein. You'll also learn when weight loss resistance is real, how to tell if your metabolism has adapted, and when it's time to look deeper at things like hormones, stress, gut health, and sleep. If you're stuck, frustrated, or feel like nothing is working, this episode will help you understand what's missing and what to do next. Get your Labs Freebie here!  Join Mindset. Movement. Metabolism here! 

Want a ceramic coating that's actually EASY to use… and actually LASTS? In this episode, I break down why most ceramic coatings fail—and why so many detailers get blamed for it when it's really the product that's the problem. The truth is… if a ceramic coating requires perfect conditions, crazy prep, and zero margin for error, that's not on you—that's on the brand. Today, I'm talking about a different approach. I'll show you why coatings like Gloss Boss and Tough As Shell are: Extremely forgiving during installation Nearly impossible to mess up Resistant to being accidentally removed And built to actually last in real-world conditions We'll also cover something most companies won't talk about…

This week we review a recent Australian prospective assessment of aspirin resistance in children undergoing heart surgery. How common is this seen in this patient group and what are the reasons? What is the best test to perform to assess this and what tests may not be worthwile? Who deserves 'routine' testing for this possible problem? Cardiovascular surgeon Dr. Supreet Marathe of Queensland Children's Hospital in Brisbane, Australia shares the results of this recent publication. DOI: 10.1016/j.jtcvs.2025.09.013

A new proposal for Bitcoin Quantum Computing resistance dropped this week, and we have an update on state-by-state data center moratoriums. Get your tickets to OPNEXT 2026 before prices increase! Join us on April 16 in NYC for technical discussions, investor talks, and intimate conversation with the brightest minds in Bitcoin. Welcome back to Block Space Live! Today, Luxor's Kaan Farahani Luxor and MIT DCI Director Neha Narula join us to respectively discuss  the wild volatility of Bitcoin mining in Q1 and the question of Bitcoin's quantum resistance. For news, explore a new stop-gap quantum-safe transaction fix that avoids soft forks, map out the states placing moratoriums on AI data center builds, and discuss the geopolitical shift of Iran accepting bitcoin for oil export tolls. We also break down reports of a buyer interest in Gemini's defunct UK and European business arms and Nakamoto's reverse stock split. Subscribe to the newsletter! https://newsletter.blockspacemedia.com Notes: * New quantum proposal costs ~$200 per transaction * Compute time takes roughly 6 hours * March difficulty drop ranked 10th at 7.76% * February saw 11.16% difficulty drop * Maine bans data centers >20MW until 2027 * Buyer interested in Gemini's shuttered UK/EU exchange businesses  *NAKA seeks 1-for-20 or 1-for-50 reverse stock split Timestamps: 00:00 Start 02:42 Hashrate Index Update 05:04 Quantum proposal-palooza 15:54 Kaan Farahani 32:42 Neha Narula 48:39 Datacenter Bans 1:02:25 Gemini 1:06:59 NAKA scramble to remain on Nasdaq 1:13:59 Iran & Bitcoin

The typical story about disease and vegetables is something like this from the all natural crowd…. Just use compost and good organic fertility, build good soil and it won’t be a problem. Yea, um, about that, look good soil, good fertility and abundant soil life and minerals go a long way to healthy plants, but they don’t eliminate all diseases.  They also take time to develop in your garden soil.  Some years my beans develop a fungus referred to as rust.  Why?  It is typical when it is wetter then normal.  In those years the same beds are growing jalapenos … Continue reading →

The post How to Design AI-Resistant Writing Before, During, and After the Writing Process appeared first on Spencer Education.

2. Taiwanese Nuclear Policy and Barksdale Drone Incursions Guest: Henry Sokolski Summary: Taiwanconsiders restarting nuclear plants to mitigate energy desperation. Meanwhile, jam-resistant drone swarms at Barksdale Air Force Base suggest potential Chinese interference intended to delay American responses to nuclear-related operations. (2)1919 CIVIL WAR

The worst carb for your health isn't sugar. Discover the most damaging carb that can spike your blood sugar even more than sugar. Learn which bad carbs to avoid to protect your metabolism and overall health.0:00 Introduction: The most damaging carb0:16 Carbs that spike blood sugar1:51 Maltodextrin and refined carbohydrates3:47 Unhealthy foods to avoid4:06 Why you should avoid this carbohydrate7:47 Resistant maltodextrin Download Dr. Berg's Free Daily Health Routine: https://drbrg.co/45qtO07Some of the most unhealthy foods don't contain any sugar! Maltodextrin is in 60% of our foods, and most people don't even know it's there. Although maltodextrin spikes your blood sugar significantly more than sugar and glucose, it's not classified as a sugar; it's classified as a complex carbohydrate.Maltodextrin is found in infant formula, protein powder, and weight gain shakes. Maltodextrin and other industrial starches, such as cornstarch and modified food starch, are used as fillers to add bulk to a product. Not only does maltodextrin contribute to blood sugar issues, weight gain, and a fatty liver, but it also does the following:• Destroys the gut lining• Supports the colonization of Salmonella and other pathogens• Depletes vitamin B1Avoid this carbohydrate! Dr. Eric Berg DC Bio:Dr. Berg, age 60, is a chiropractor who specializes in Healthy Ketosis & Intermittent Fasting. He is the Director of Dr. Berg Nutritionals and author of the best-selling book The Healthy Keto Plan. He no longer practices, but focuses on health education through social media.Disclaimer: Dr. Eric Berg received his Doctor of Chiropractic degree from Palmer College of Chiropractic in 1988. His use of “doctor” or “Dr.” in relation to himself solely refers to that degree. Dr. Berg is a licensed chiropractor in Virginia, California, and Louisiana, but he no longer practices chiropractic in any state and does not see patients, so he can focus on educating people as a full-time activity, yet he maintains an active license. This video is for general informational purposes only. It should not be used to self-diagnose, and it is not a substitute for a medical exam, cure, treatment, diagnosis, prescription, or recommendation. It does not create a doctor-patient relationship between Dr. Berg and you. You should not make any change in your health regimen or diet before first consulting a physician and obtaining a medical exam, diagnosis, and recommendation. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition.